A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Clinical trial NCT03153111 · COMPLETED
Trial details
- NCT number
- NCT03153111
- Sponsor
- Actelion
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-11
- Primary completion
- 2021-03-12
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.